Three independent discounted-cash-flow-style models value Elevance Health, Inc. every trading day. 2 of 3 currently price ELV above its market price.
| Free Cash Flow model | $717.47 |
| Excess Profit model | $800.27 |
| Residual Earnings model | $279.49 |
| Dividend Discount model | $183.18 |
| Piotroski F-Score | 7 / 9 |
| Return on invested capital | +7.5% |
| Net debt / EBITDA | 3.1× |
| Gross margin | +89.4% |
| Revenue CAGR | +8.3% |
| Cash conversion | 0.8× |
| Dividend yield | +1.7% |
| Buyback yield | +3.3% |
These are StockKitty's default assumptions. In the app, the models recompute live as you adjust growth, discount rates, and margins — and the AI explains the bull case, bear case, and quality picture.
Open ELV in StockKitty